chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal, Metabolic function test, Nausea, Paraesthesia
Clinical narrative: Dizziness, vertigo, numbness on the left side of my body, nausea.; Dizziness, vertigo, numbness on the left side of my body, nausea.; Dizziness, vertigo, numbness on the left side of my body, nausea.; Dizziness, vertigo, numbness on the left side of my body, nausea.; This is a spontaneous report received from a contactable consumer (patient). A 32-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 15Mar2021 at 13:30 (at the age of 32-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included lupus. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. On 17Mar2021 at 12:00 the patient experienced dizziness, vertigo, numbness on the left side of the body, and nausea. The patient visited a doctor or other healthcare professional office/clinic and an emergency room/department or urgent care as a result of the events. The patient did not receive any treatment for the events. The outcomes of dizziness, vertigo, numbness on the left side of the body, and nausea were not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Red blood cell sedimentation rate normal, Scan with contrast abnormal, Thyroxine free normal, Urine analysis abnormal, Vertigo
Clinical narrative: Dizziness, vertigo, numbness on the left side of my body, nausea.; Dizziness, vertigo, numbness on the left side of my body, nausea.; Dizziness, vertigo, numbness on the left side of my body, nausea.; Dizziness, vertigo, numbness on the left side of my body, nausea.; This is a spontaneous report received from a contactable consumer (patient). A 32-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 15Mar2021 at 13:30 (at the age of 32-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included lupus. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. On 17Mar2021 at 12:00 the patient experienced dizziness, vertigo, numbness on the left side of the body, and nausea. The patient visited a doctor or other healthcare professional office/clinic and an emergency room/department or urgent care as a result of the events. The patient did not receive any treatment for the events. The outcomes of dizziness, vertigo, numbness on the left side of the body, and nausea were not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Visual impairment
Clinical narrative: Dizziness, vertigo, numbness on the left side of my body, nausea.; Dizziness, vertigo, numbness on the left side of my body, nausea.; Dizziness, vertigo, numbness on the left side of my body, nausea.; Dizziness, vertigo, numbness on the left side of my body, nausea.; This is a spontaneous report received from a contactable consumer (patient). A 32-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 15Mar2021 at 13:30 (at the age of 32-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included lupus. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. On 17Mar2021 at 12:00 the patient experienced dizziness, vertigo, numbness on the left side of the body, and nausea. The patient visited a doctor or other healthcare professional office/clinic and an emergency room/department or urgent care as a result of the events. The patient did not receive any treatment for the events. The outcomes of dizziness, vertigo, numbness on the left side of the body, and nausea were not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Pain
Clinical narrative: I feel pain in my clavicle area (right side).; I can feel a lump that feels tender and sore.; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EP8955) via an unspecified route of administration on 28Mar2021 at 11:15 (at the age of 54-years-old) as a single dose in the right arm for COVID-19 immunization. The patient had no medical history. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine.  Concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 (lot number EN6805) on 07Mar2021 at 11:00 as a single dose in the left arm for COVID-19 immunization. The patient did not have any allergies to medications, food, or other products. On 29Mar2021 at 20:30 the patient experienced pain in the clavicle area on the right side. She felt a lump that felt tender and sore. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcome of pain in clavicle area on the right side and lump that felt tender and sore was not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.    No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Testicular pain
Clinical narrative: fatigue; muscle aches; testicular pain; This is a spontaneous report received from a contactable consumer (patient). A 46-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 30Mar2021 at 13:00 (at the age of 46-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Prior to the vaccine, the patient was not diagnosed with COVID-19. The patient took unspecified concomitant medications. The patient did not have any allergies to medications, food, or other products. On 31Mar2021 at 07:00 the patient experienced fatigue, muscle aches, and testicular pain. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcome of fatigue, muscle aches, and testicular pain was not recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19 immunization.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm soreness.; This is a spontaneous report received from a contactable consumer (patient). A 74-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 14Mar2021 at 11:30 (at the age of 74-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included vitamin B, vitamin C, hemp, biotin, lutein, aloe vera, and chlorzoxazone, paracetamol (GIN). The patient did not have any allergies to medications, food, or other products. On 17Mar2021 at 16:00 the patient experienced arm soreness. The event was reported as non-serious. The patient was not hospitalized for the event. The patient did not receive any treatment for the event. The outcome of arm soreness was recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Fatigue, Hypopnoea, Muscle tightness
Clinical narrative: Within 20mins feeling tired; Muscles are tightening more than usual.; Joint pain, more than usual.; Breathing is shallow and takes effort to draw in.; Breathing is shallow and takes effort to draw in.; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 50-year-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in the right arm on 31Mar2021 at 11:00 (Batch/Lot Number: Er8732) at 50-years-old as a single dose for COVID-19 immunization. The patient did not receive any other vaccine within four weeks of the suspect vaccine.  The patient did not have COVID prior to the vaccination.  Medical history included rheumatoid arthritis (RA) from an unknown date and unknown if ongoing, lupus from an unknown date and unknown if ongoing, fibromyalgia from an unknown date and unknown if ongoing, sulfonamide allergy from an unknown date and unknown if ongoing.  Concomitant medications included unspecified medications from an unknown date to an unknown date; within 2 weeks of vaccination. On 31Mar2021 at 11:30, the patient experienced: within 20 mins feeling tired, muscles are tightening more than usual, joint pain, more than usual, breathing is shallow and takes effort to draw in; all considered non-serious and no treatment was received.  The clinical outcome of the events was unknown. The patient was not tested for COVID post vaccination.    No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold, Hypersomnia
Clinical narrative: Fatigue; Sleeping 10-12 hours most nights; felt cold (not chills); This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: ER8732), via an unspecified route of administration in the left arm, on 23Mar2021 at 14:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included hypogammaglobulinemia immunoglobulin A (IGA) (no IGA present in blood). The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ascorbic acid (VITAMIN C), vitamin D (MANUFACTURER UNKNOWN), cyanocobalamin (VITAMIN B12), and naproxen sodium (ALEVE). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced fatigue, sleeping 10-12 hours most nights, and felt cold (not chills) on 25Mar2021 at 09:30. The events were reported as non-serious. The events were described as: The fatigue set in about 36 hours (as reported) after the vaccine and the patient has been fatigued for 6 days. He has been sleeping 10-12 hours most nights and each day gets a little better. He has felt cold (not chills) and so has been wearing additional clothes, blankets at night and turned up heat in the house. The patient did not receive any treatment as a result of the events. The clinical outcome of fatigue, sleeping 10-12 hours most nights, and felt cold (not chills) was recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Eye swelling, Hangover, Headache
Clinical narrative: hangover like headache; hangover like headache; right eye was swollen and painful; right eye was swollen and painful; This is a spontaneous report from a contactable physician, reporting for herself. A 33-year-old non-pregnant female patient received the second dose of the bnt162b2 (BNT162B2), via an unspecified route on 27Mar2021 at a single dose of administration for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. There were no allergies to medications, food, or other products. The patient previously received the first dose of the bnt162b2 on 06Mar2021 at a single dose for covid-19 immunisation. No other vaccines administered within 4 weeks prior to the immunization. In Mar2021 (reported as 01Mar2021), the patient experienced hangover like headache for one day and morning right eye was swollen and painful, which required physician office visit. The events were further described as: hangover like headache for one day, resolved by next day, Monday morning right eye was swollen and painful. Therapeutic measures were taken in response to the events. There was no covid-19 prior to or post vaccination. The clinical outcome of the events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity, Pyrexia
Clinical narrative: Chills; Fever started about 14 hours post vaccine; Body aches started about 10 hours post vaccine.; Sore arm; This is a spontaneous report from a non-contactable consumer (patient). A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in the left arm on 30Mar2021 at 11:00 (Batch/Lot Number: EL3247) at 38-years-old as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient previously took bnt162b2 for COVID-19 immunization on 09Mar2021 (Dose 1, 11:00, left arm, Lot EL3247). On 30Mar2021 at 21:00, the patient experienced body aches started about 10 hours post vaccine (non-serious). On 31Mar2021 at 01:00, the patient experienced chills (non-serious) and fever started about 14 hours post vaccine (non-serious). On an unspecified date in 2021, the patient experienced sore arm (non-serious).  The clinical outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Skin disorder
Clinical narrative: Pain on left foot - feels like a small bump; Pain on left foot - feels like a small bump; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm on 31Mar2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced pain on left foot - feels like a small bump on 31Mar2021. The event was reported as non-serious. The patient did not receive any treatment as a result of the event. The clinical outcome of pain on left foot - feels like a small bump was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Flushing, Hyperhidrosis
Clinical narrative: flushed hot face; sweaty head; BP 160/90; This is a spontaneous report from a contactable consumer, reporting for herself. A 66-year-old non-pregnant female patient received the second dose (Lot Number: ER8732) of the bnt162b2 (BNT162B2), via an unspecified route of administration in the left arm on 30Mar2021 at 13:30 at a single dose for covid-19 immunisation. Medical history included sleep apnea, asthma, obesity, anxiety (antidepressants for 35 years), and allergy to lemon, lime, green peppers, mushrooms, walnuts. Concomitant medications included fluticasone furoate/vilanterol trifenatate (BREO ELLIPTA); tiotropium bromide (SPIRIVA); albuterol [salbutamol] (MANUFACTURER UNKNOWN); duloxetine hydrochloride (CYMBALTA); vitamin d3 (MANUFACTURER UNKNOWN); vitamin c [ascorbic acid] (MANUFACTURER UNKNOWN). The patient previously received furosemide (MANUFACTURER UNKNOWN) and theophylline (MANUFACTURER UNKNOWN) and experienced drug allergy to both on unspecified dates. The patient previously received the first dose of the bnt162b2 (Lot Number: EN6206) on 09Mar2021 13:00 at a single dose in the left arm at 66 years of age for covid-19 immunisation. There were no other vaccinations within 4 weeks prior to vaccination with bnt162b2. There was no covid-19 prior to or post vaccination with bnt162b2. On 30Mar2021 at 14:00, the patient experienced 30 minutes after shot, while still sitting in the post-shot waiting area: flushed hot face, sweaty head, BP 160/90, which were non-serious. BP was 130/72 just before going to the get the shot on 30Mar2021. There was no therapeutic measures were taken as a result of the events. The clinical outcome of the events was recovered after about 30 minutes on an unknown date. The patient fully recovered within an hour.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia
Clinical narrative: Fever, body aches, headache, nausea; Fever, body aches, headache, nausea; Fever, body aches, headache, nausea; Fever, body aches, headache, nausea; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 49-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in the left arm on 30Mar2021 at 12:45 (Batch/Lot number was not reported) at 49-years-old as a single dose for COVID-19 immunization. The patient did not receive any other vaccine within four weeks of the suspect vaccine. The patient did not have COVID prior to the vaccination.  Medical history included High blood pressure, depression; both from an unknown date and unknown if ongoing. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, start and stop date were not reported; lisinopril dihydrate (MANUFACTURER UNKNOWN) taken for an unspecified indication, start and stop date were not reported; within 2 weeks of vaccination.  The patient previously took bnt162b2 for COVID-19 immunization 03Mar2021 at 49-years-old (administration time=17:00, vaccine location=Left arm, dose number=1), codeine (MANUFACTURER UNKNOWN) and experienced allergy on an unspecified date. On 30Mar2021 at 23:30, the patient experienced: fever, body aches, headache, nausea; all non-serious and for which no treatment was received. The clinical outcome of the events was not recovered. The patient was not tested for COVID post vaccination.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Vaccination site pain
Clinical narrative: Slight headache; chills; soreness at injection site; lightheadedness; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on 30Mar2021 at 08:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer, neuropathy, and pre-diabetes. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atorvastatin calcium (LIPITOR), herbal pollen (RELIZEN), and unspecified multivitamins. The patient previously took cefazolin sodium (KEFZOL) and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced slight headache, chills, soreness at injection site, and lightheadedness on 30Mar2021 at 09:00. The patient did not receive any treatment as a result of the events. The clinical outcome of slight headache, chills, soreness at injection site, and lightheadedness was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Eating disorder, Headache, Lethargy, Sleep disorder, Vomiting
Clinical narrative: throwing up; lethargy; Terrible headache; Sleep for; could not eat or function; This is a spontaneous report from a contactable consumer, reporting for herself.  A 35-year-old non-pregnant female patient received the second dose of the bnt162b2 (BNT162B2; Lot Number: ER8737), via an unspecified route of administration in the left arm on 28Mar2021 at 12:00 at a single dose for covid-19 immunisation. There was no medical history. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN); topiramate (MANUFACTURER UNKNOWN); methylprednisolone (MANUFACTURER UNKNOWN); and drospirenone/ethinylestradiol (GIANVI). The patient previously received the first dose (Lot Number: ER8737) of the bnt162b2 on 06Mar2021 at 11:15 at 35 years of age at a single dose for covid-19 immunization. No other vaccinations given 4 weeks prior to the immunization. In Mar2021 (reported as 01Mar2021), the patient was throwing up, lethargy, terrible headache, sleep, and could not eat or function. Therapeutic measures were taken as a result of terrible headache (headache). There was no treatment given in response to the other events. There was no covid prior to or post vaccination. The clinical outcome of the events was recovered on an unknown date.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: severe taste of garlic; This is a spontaneous report from a contactable consumer (patient). A 70-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration on 23Feb2021 (Batch/Lot Number: EN 6200) at 70-years-old as a single dose for COVID-19 immunization. The patient did not receive any other vaccine within four weeks of the suspect vaccine. The patient did not have COVID prior to the vaccination.  The patient's medical history included allergies to bees and wasps from an unknown date and unknown if ongoing. Concomitant medications were not reported. The patient previously received the bnt162b2 for COVID-19 immunization on 02Feb2021 at 70-years-old (Lot Number: EL 9265, administration time: 10:00, vaccine location: Left arm, dose number: 1). On 03Mar2021 at 12:00, the patient experienced severe taste of garlic (non-serious), where gum and mints did not help. There were no therapeutic measures taken, however, a physician office visit was required. The clinical outcome of the event was not recovered. The patient was not tested for COVID post vaccination.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing and hissing sound in ears; This is a spontaneous report from a contactable consumer (patient). A 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included gluten allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced ringing and hissing sound in ears on 24Mar2021, which was reported as non-serious. The patient did not receive any treatment as a result of the event. The clinical outcome of ringing and hissing sound in ears was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular hyperaemia, Pain in extremity
Clinical narrative: small red spot on right eye; Pain in left arm; This is a spontaneous report from a contactable consumer, reporting for herself. A 34-year-old non-pregnant female patient received the first dose of the bnt162b2 (BNT162B2; Lot Number: ER87Z7), via an unspecified route of administration in the left arm on 29Mar2021 at 13:45 at a single dose for covid-19 immunisation. Medical history included polycystic ovary syndrome (PCOS), fibromyalgia, rheumatoid arthritis, Hoshimoto's, and hypothyroidism. There were no known allergies. Concomitant medications included unspecified thyroid prescription, pain reliever, vitamins and supplements (as reported), given in two weeks. There were no other vaccinations given in prior four weeks. On 29Mar2021, the patient experienced small red spot on right eye and pain in left arm for two days, which were non-serious. There was no treatment given in response to the events. There was no covid prior to or post vaccination. The clinical outcome of the events was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report from a contactable consumer, reporting for herself. A 57-year-old female non-pregnant patient received the first dose of the bnt162b2 (BNT162B2; Lot Number: EN6206), via an unspecified route of administration on 08Mar2021 at 16:00 in the left arm at a single dose for covid-19 immunisation. The patient received the vaccinations in a health clinic/administration facility. The medical history was not reported. There were no allergies to medications, food, or other products. Concomitant medications included colecalciferol (VITAMIN D [COLECALCIFEROL]); biotin (BIOTIN). No other vaccinations administered within 4 weeks prior to bnt162b2 vaccination. On 31Mar2021, the patient experienced sore arm for 1 day, which were non-serious. There was no treatment given in response to the event. There was no covid prior to or post bnt162b2 vaccination. The clinical outcome of the event not recovered.  No follow-up attempts are required. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: flu-like symptoms; This is a spontaneous report received from a contactable consumer (reporting for her daughter). A 17-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration on 01Apr2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the second Pfizer COVID-19 vaccine dose yesterday, 01Apr2021. The patient was experiencing flu-like symptoms today, 02Apr2021. The outcome of the event was not recovered.     No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: ringing of ears; This is a spontaneous report received from a contactable consumer (the patient). A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration on 04Mar2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. A week after getting her first dose, the patient experienced ringing of ears in Mar2021. The patient received her second dose on 24Mar2021. The outcome of the event was unknown.      No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This is a spontaneous report from a Pfizer Sponsored Program . A non-contactable consumer (patient) reported a female patient of unspecified age received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date the patient experienced dizziness when she received BNT162B2. The outcome of dizziness was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: kind of pretty rough headache; Kind of feeling nauseous; This is a spontaneous report from a contactable consumer, the patient. A patient of an unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot unknown, first dose) solution for injection intramuscular on 28Mar2021 (at an unknown age) as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. On 30Mar2021, the patient had a kind of pretty rough headache and was kind of felling nauseous. The outcome of the events headache and nauseous was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm slightly sore at the injection site starting in the evening on the day of vaccination; This is a spontaneous report from a contactable consumer. A 47-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: ER2613), via an unspecified route of administration on arm Left on 24Mar2021 01:15 PM at single dose for COVID-19 immunization. The patient medical history included hypertension. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19 The patient Concomitant medications included lisinopril hydrochloride, nasacort, Claritin, Benadryl. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 24Mar2021 07:00 PM, the patient experienced Arm slightly sore at the injection site starting in the evening on the day of vaccination. The patient did not receive any treatment for the events. The outcome of the events was recovered.  Follow-up#01(16Apr2021): Upon follow up, new information included patient concomitant medications.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Migraine
Clinical narrative: headaches; bad migraine/Migraine headache and headache which has not improved; This is a spontaneous report from a contactable consumer. A 61-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 16Mar2021 14:30 (Lot Number: EN 6208, Expiration date: unknown) as single dose for covid-19 immunisation. The patients medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced the day after he took the shot on 17Mar2021, a migraine, it was awful, the migraine came down to a headache and he haven't had that level of migraine. Since then his headache is not gone away and he does not know if he has migraine right now but it was not improved on 17Mar2021. Patient reported he was not going to take the second shot. But he is scheduled to take the second shot tomorrow, but there is no way he could take that. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were taken as a result of bad migraine. Nabumetone 500 mg twice a day was taken as treatment for migraine. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Computerised tomogram head, Headache, Magnetic resonance imaging head, Migraine
Clinical narrative: headaches; bad migraine/Migraine headache and headache which has not improved; This is a spontaneous report from a contactable consumer. A 61-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 16Mar2021 14:30 (Lot Number: EN 6208, Expiration date: unknown) as single dose for covid-19 immunisation. The patients medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced the day after he took the shot on 17Mar2021, a migraine, it was awful, the migraine came down to a headache and he haven't had that level of migraine. Since then his headache is not gone away and he does not know if he has migraine right now but it was not improved on 17Mar2021. Patient reported he was not going to take the second shot. But he is scheduled to take the second shot tomorrow, but there is no way he could take that. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were taken as a result of bad migraine. Nabumetone 500 mg twice a day was taken as treatment for migraine. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Scan with contrast
Clinical narrative: headaches; bad migraine/Migraine headache and headache which has not improved; This is a spontaneous report from a contactable consumer. A 61-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 16Mar2021 14:30 (Lot Number: EN 6208, Expiration date: unknown) as single dose for covid-19 immunisation. The patients medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced the day after he took the shot on 17Mar2021, a migraine, it was awful, the migraine came down to a headache and he haven't had that level of migraine. Since then his headache is not gone away and he does not know if he has migraine right now but it was not improved on 17Mar2021. Patient reported he was not going to take the second shot. But he is scheduled to take the second shot tomorrow, but there is no way he could take that. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were taken as a result of bad migraine. Nabumetone 500 mg twice a day was taken as treatment for migraine. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: headache; very tired; pain and tenderness at injection site; This is a spontaneous report from a contactable consumer (patient). A 52-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient experienced headache, very tired and pain and tenderness at injection site on an unspecified date. Outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Gait inability, Myalgia
Clinical narrative: weakness; her right leg started having muscle pain; she could only drag her leg (couldn't walk); This is a spontaneous report from a contactable consumer (patient's friend). A female patient of unspecified age received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 24Mar2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 on an unspecified date as a single dose for COVID-19 immunization. On 26Mar2021 at night, which was 48 hours after dose 2 of BNT162B2, the patient experienced right leg started having muscle pain to a point where she could only drag her leg; she couldn't walk. The patient was treated with an anti-inflammatory medication which took care of the worst of it but she had weakness on 27Mar2021 and some on 28Mar2021. The patient was fine by 29Mar2021 and the outcome of weakness was recovered. The outcomes of right leg started having muscle pain and she couldn't walk were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Malaise, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; Stomach pains; Overall not feeling well; This is a spontaneous report received from a contactable consumer (patient). A 51-year old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; LOT NUMBER EN6203) intramuscularly on 26Feb2021 at 10:45 (at the age of 51-years-old) as a single dose for COVID-19 immunization. Medical history included a positive COVID-19 test on 28Nov2020. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 on 05Feb2021 at 11:00 (lot number EN9581) as a single dose for COVID-19 immunization. On 26Feb2021 at 16:00, the patient experienced fever, stomach pains, and overall not feeling well lasted 48 hours. The patient did not receive any treatment for the events. The outcomes of fever, stomach pains, and not feeling well were recovered after 48 hours.   No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Malaise, Thinking abnormal, Tremor
Clinical narrative: exhausted/tiredness; She says she feels a little fuzzy, like she is not thinking clearly; Discomfort; mild malaise; Trembling; This is a spontaneous report from a contactable consumer (Patient). A 79-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EN6202; Expiry Date: 30Jun2021), administered in left arm on 03Mar2021 (at the age of 79-years) as SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced discomfort, mild malaise, trembling, on an unspecified date she says she feels a little fuzzy, like she was not thinking clearly and she says she was not able to do anything due to exhaustion. she has been having three days of discomfort and mild malaise for a week. The patient says she was not able to do anything due to exhaustion, so she thought Pfizer would want to know. She says that she could not type due to trembling to complete a report online. Patient second dose was on 26Mar2021, and they did not ask for her vaccine card, so she does not have and was not able to provide NDC/LOT/EXP from the second dose. She says that the NDC was not provided on her vaccine card for the first dose. The patient mentions a COVID test, but says that this was just a paper, she had forgot that she had a card, the test was to do a job. Patient says it was the second dose that she had a reaction after. She says she got both doses in her left arm. She says her reaction was discomfort and mild malaise beginning Saturday. Patient said that it has not got better or worse, she was having intermittent trembling periods where she would feel ok but then start shaking and be exhausted again, so it has been about the same since Saturday. Patient said that she will be ok for a couple hours, and then it will all start again, and she will shake all over. Patient felt a little fuzzy, like she was not thinking clearly, and so tired and trembling. The patient said that her prolonged reaction was not enough to go to the hospital, but she was not feeling so good, and thinks maybe people should be warned. The patient did not receive any treatment for adverse event. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Nasal congestion, Rash
Clinical narrative: shingles.; rash; he developed the rash and stuff 2-3 days after the 2nd dose of the Pfizer COVID Vaccine; This is spontaneous report from a Pfizer sponsored program. A contactable 63-year-old male consumer received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown, expiration date unknown), via an unspecified route of administration on 31Mar2021 at the age of 65 years old as single dose for COVID-19 immunisation. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown, expiration date unknown). The patient medical history and concomitant medications were not reported. Caller states with the 1st dose he did fine and went for the 2nd dose of the Pfizer COVID Vaccine and did not realize he was in the beginning stages of shingles and felt fine. States he just wanted to see if the 2nd dose of the vaccine is going to work and he developed the rash and stuff 2-3 days after the 2nd dose of the Pfizer COVID Vaccine and states it has nothing to do with the vaccine but he just developed the illness regarding shingles. caller states he is wondering if the vaccine is still effective. The outcome of the events was reported as not recovered.  No follow-up attempts are needed; information about lot/batch number
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: tested positive for COVID with symptoms; This is a spontaneous report from a Pfizer sponsored program, received from a contactable consumer (patient). A 60-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported), via an unspecified route of administration on 15Mar2021 as single dose for covid-19 immunization on an unspecified facility. Medical history included exposed with someone who has COVID on 22Mar2021. The patient's concomitant medications were not reported. On 25Mar2021 (also reported as 11 days after first dose), it was reported that the patient was experiencing symptoms, the patent was tested positive for COVID. He is scheduled for the 2nd dose last 05Apr2021 but he missed the appointment due to COVID infection. Patient would like to know what recommendation for him on getting second dose post COVID infection. He mentioned that he is asymptomatic for a week now. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Erythema, Rash
Clinical narrative: Caller states it was very low, didn't think much of it, then it got worse.; she got a severe rash all over her body; she has her neck and back in flame red color with spots; This is a spontaneous report received from a contactable consumer (reporting on herself). A 76-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and Expiry date was not reported), via an unspecified route of administration on 01Apr2021 14:00 as single dose for COVID-19 immunization. Medical history included blood pressure measurement from an unknown date and unknown if ongoing. Concomitant medication(s) included oxytetracycline (TERRAMYCINE [OXYTETRACYCLINE]) taken for blood pressure measurement, start and stop date were not reported. patient got the first dose of the BNT162B2 on 01Apr2021 and she got a severe rash all over her body: she has her neck and back in flame red color with spots on her body and spots on her legs. She wants to know if she can take, Benadryl. Patient mentions that she was sorry the she got the shot and if she knew all the trouble she had to go through he would have never got it. She says that she will not going for the second shot after this. Aside this she mentioned that she was tired of being on the phone for 45 min while waiting for someone. And wanted to know if her insurance covered the vaccination or how does it worked. Patient states she has a bad knee and doesn't have it with her right now. Patient states she takes blood pressure pills but she feels okay. Patient states it was Terramycin, the generic. The outcome of the events she got a severe rash all over her body and she has her neck and back in flame red color with spots was not recovered and for event Caller states it was very low, didn't think much of it, then it got worse was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Headache, Influenza like illness, Pain
Clinical narrative: felt dizzy; low grade fever (99°F); she felt like if she had the flu; achy all over her body; headache; weak, it was difficult for her to get out of bed; This is a spontaneous report from a contactable consumer (patient). A 63-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: Expiry date: Unknown), dose 2 via intramuscular on 06Apr2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced dizzy, low grade fever (99°f), she felt like if she had the flu, achy all over her body, headache, weak, it was difficult for her to get out of bed on an unspecified date. The treatment included Tylenol seems to help with these symptoms, she takes it every four hours. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  No follow-up attempts are needed. No further information is expected.